Skip to content

To study the effect of Lodhra(Symplocos racemosa), Nagkeshar(Mesua ferra) & Udumbar choorna(Ficus glomerata) in Excessive menstrual bleeding.

To study effect of Lodhra, Nagkeshar & Udumbar choorna on endometriam in Raktaradara(DUB).

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/010851
Enrollment
20
Registered
2017-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Female with excessive per vaginal bleeding during menstrual phase in quantity more then 80ml and in duration more then 7 days

Interventions

Intervention1: Lodhra,Nagkeshar and Ubumbar choorna,Honey: Lodhra,Nagkeshar and Ubumbar choorna 3grams with 5ml honey orally three times a day given from first day of menstrual cycle up to three month

Sponsors

Registrar Maharashtra University Of Health Sciences Nashik
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patient with Dysfunctional Uterine Bleeding DUB.

Exclusion criteria

Exclusion criteria: Known case of Carcinoma Endometrium,cervix and genital tract Postmenopausal bleeding Pervaginal bleeding due to organic cause Thyroid Dysfunction Sever Anemia

Design outcomes

Primary

MeasureTime frame
Normalisation of per vaginal blood loss that is less then eighty ml in each cycle Normalisation of Hypertrophoid endometrium less then twelve milimeters at twenty fourth day of menstrual cycleTimepoint: Normalisation of per vaginal blood loss in three months Normalisation of Hypertrophoid endometrium in three months

Secondary

MeasureTime frame
Improvement in haemoglobinTimepoint: Improvement in haemoglobin in three months

Countries

India

Contacts

Public ContactDr Shailendra Dadarao Katakdound

Vasantdada Patil Ayurvedic Medical college & Institute of yoga, Sangli.

skatakdound@yahoo.com0233-2377133

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026